COVID and Coagulation

Abstract Number: VPB0607

A Comparison of eNOS-based Platelet Subpopulation Ratios and Platelet VEGF Content within COVID-19

A. Asgari¹, B. Ritchie², P. Jurasz³

Abstract Number: PO0012

A frequency of anti-PF4/heparin antibodies and LA in patients with COVID-19

T. KIM¹, S. Namgoong², M. Choi², H. Kim³, S. Jang⁴

Abstract Number: PB0051

A Multicenter Cohort Study of COVID-19 Associated Venous Thromboembolism in Admitted Patients Followed Longitudinally 3-Months After Discharge

C. Drury¹, C. Lai², G. Misselbrook³, A. Al Zaki², G. Bhangu⁴, M. Conroy⁵, L. Eadie⁴, D. Kumar⁶, C. Li⁵, D. Manhas⁵, N. Singh⁴, J. Yuan⁴, A. Lee², T. Wan⁷

Abstract Number: OC 13.5

A Multicenter Randomized Clinical Trial of Modulation of Host Thromboinflammatory Response in Hospitalized Patients with COVID-19: The DAWn-Antico study

M. Engelen¹, J. Wauters¹, J. Gunst¹, C. Wouters¹, C. Vandenbriele¹, S. Rex¹, M. Thomeer², T. Fivez², D. Mesotten², D. Ruttens², L. Heytens³, P. Verhamme⁴, T. Vanassche⁵

Abstract Number: VPB0141

A near real-time surveillance algorithm to identify in-hospital VITT cases

S. Williams, S. Sivapalaratnam, S. Vohra, P. Johnstone, A. Pentony, C. Gutteridge

Abstract Number: PB0045

A pilot, open-label, phase II clinical trial of nebulised recombinant tissue-plasminogen activator in patients with COVID-19 acute respiratory distress syndrome: the PACA trial

P. Chowdary¹, B. Agarwal², S. Bhagani³, M. Lipman⁴, K. Gomez⁵

Abstract Number: PB0054

A role for Von Willebrand Factor-ADAMTS13 axis imbalance and abnormal angiogenesis in Long COVID syndrome

H. Fogarty¹, S. Ward², L. Townsend³, E. Karampini², S. Elliott⁴, M. Byrne⁵, C. Bergin³, J. O'Sullivan⁶, I. Martin-Loeches⁷, P. Nadarajan⁸, C. Bannon³, R. Preston⁹, A. Rehill², C. Ni Cheallaigh³, J. O'Donnell²

Abstract Number: PB0604

Abridging Molecular System Network of COVID-19 and Thrombosis

M. Hussain¹, A. Amanullah¹, N. Jabeen², B. Kantarcioglu³, F. Siddiqui³, J. Fareed³

Abstract Number: OC 33.3

Absence of Hypercoagulability after nCoV-19 Vaccination: an observational longitudinal study

C. Simion¹, E. Campello², C. Bulato¹, L. Spiezia³, D. Tormene⁴, C. Radu¹, S. Gavasso¹, N. Perin¹, M. Sartori³, P. Simioni⁵

Abstract Number: PB0600

ADAMTS13 activity and non-parallel vWF Ristocetin CoFactor activity are associated with severity of COVID-19 infection

S. MacDonald¹, D. White¹, S. Cox-Morton¹, M. Sharp¹, E. Duff¹, C. Bridgeman¹, T. Edwards¹, C. Moore¹, E. Vilar², M. Besser¹, E. Symington¹, M. Robinson¹, W. Thomas¹

Abstract Number: PB0091

ADAMTS13 in the diagnosis of the severity of COVID-19 mortality

L. Slavík¹, J. Ulehlova¹, P. Bradacova², M. Jancova³, J. Prochazkova¹, A. Hlusi¹

Abstract Number: VPB0611

Alteration of circulating ACE2 regulating microRNAs profiles in patients with COVID-19

Z. Wicik¹, C. Eyileten¹, J. Jarosz-Popek¹, D. Jakubik¹, A. Nowak¹, M. Wolska², A. Shahzadi³, D. Martins-Jr⁴, S. Simões⁵, J. Siller-Matula⁶, M. Postula¹

Abstract Number: VPB0130

Alterations in the coagulation profile and mortality due to covid-19 during the first and second wave in peruvians: A retrospective cohort in a national reference center.

R. Pichardo-Rodriguez¹, W. Peña-Oscuvilca², L. cordova-Cueva³, J. DE LA CRUZ-VARGAS⁴, O. Ruiz-Franco², F. Garmendia-Lorena²

Abstract Number: PB0592

Altered Fibrin Network Structure and Fibrinolysis in Intensive Care Unit Patients with COVID-19, Not Entirely Explaining the Increased Risk of Thrombosis

J. de Vries¹, C. Visser¹, L. Geers², J. Slotman³, N. van Kleef⁴, C. Maas⁵, H. Bax⁶, J. Miedema⁷, E. van Gorp⁸, M. Goeijenbier⁹, J. van den Akker¹⁰, H. Endeman¹⁰, D. Rijken², M. Kruip², M. de Maat¹¹

Abstract Number: VPB0612

Angiostatin and Plasminogen Levels as Risk Factors for Mortality in Hospitalized Covid-19 Patients

A. Franczak¹, S. Rathwell², W. Alemayehu², P. Jurasz³

Abstract Number: OC 33.5

Anti-PF4 IgG levels in patients with VITT remain high at 7 months following vaccination and can still activate platelets

S. Montague¹, C. Smith², C. Lodwick³, C. Stoneley⁴, M. Roberts⁴, G. Lowe⁵, W. Lester⁴, S. Watson¹, P. Nicolson⁶

Abstract Number: PB0596

Anti-SARS-CoV-2 vaccines do not induce a hypercoagulable state in healthy individuals

L. Garabet¹, A. Eriksson², E. Tjønnfjord³, M. Olsen³, H. Jacobsen², C. Tøvik Jørgensen², Å. Mathisen², M. Mowinckel⁴, M. Ahlen⁵, I. Sørvoll⁵, P. Sandset⁶, W. Ghanima⁷

Abstract Number: PB0076

Antiphospholipid antibodies in patients with acute ischaemic stroke during the COVID-19 pandemic

P. Mittal¹, M. Efthymiou², R. Simister³, Z. Sayar⁴, A. Chandratheva³, D. Werring³, H. Cohen⁵

Abstract Number: PB0042

Antithrombotics and antihistamine use correlated with increased COVID-19 severity. Antithrombotics and antihistamine use correlated with increased COVID-19 severity.

M. Khan¹, V. Chan², C. Maynard², I. Asekomhe², M. Brennan¹

Abstract Number: PB0080

Are drug-drug interactions clinically relevant?. Use of edoxaban concomitant to ritonavir in COVID-19 hospitalized patients with atrial fibrillation

P. Olivera¹, D. Campoy¹, C. Velásquez-Escandón², T. Canals³, K. Flores⁴, E. Johansson⁴, C. Hernandez⁵, O. Benitez⁵